CASCADES INC. CIBC Conference Montreal September 22, 2016 - - PowerPoint PPT Presentation

cascades inc
SMART_READER_LITE
LIVE PREVIEW

CASCADES INC. CIBC Conference Montreal September 22, 2016 - - PowerPoint PPT Presentation

CASCADES INC. CIBC Conference Montreal September 22, 2016 DISCLAIMER Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of securities


slide-1
SLIDE 1

CASCADES INC.

CIBC Conference – Montreal September 22, 2016

slide-2
SLIDE 2

DISCLAIMER

2

Certain statements in this presentation, including statements regarding future results and performance, are forward-looking statements within the meaning of securities legislation based on current expectations. The accuracy of such statements is subject to a number of risks, uncertainties and assumptions that may cause actual results to differ materially from those projected, including, but not limited to, the effect of general economic conditions, decreases in demand for Cascades Inc.’s (“Cascades,” “CAS,” the “Company,” the “Corporation,” “us” or “we”) products, the prices and availability of raw materials, changes in the relative values of certain currencies, fluctuations in selling prices and adverse changes in general market and industry conditions. This presentation may also include price indices as well as variance and sensitivity analyses that are intended to provide the reader with a better understanding of the trends related to our business activities. These items are based

  • n the best estimates available to the Company.

The financial information included in this presentation also contains certain data that are not measures of performance under IFRS (“non-IFRS measures”). For example, the Company uses operating income before depreciation and amortization (“OIBD” which, for purposes of this presentation, we call “EBITDA”) and operating income before depreciation and amortization (excluding specific items) (“OIBD (excluding specific items)” which, for purposes of this presentation, we call “EBITDA (excluding specific items)”) because such measures are used by management to assess the operating and financial performance of the Company’s operating segments. Such information is reconciled to the most directly comparable financial measures, as set forth in the “Supplemental Information on Non-IFRS Measures” section of our most recent quarterly report or annual report. Specific items are defined as items such as charges for or reversal of impairment of assets, for facility or machine closures, accelerated depreciation of assets due to restructuring measures, premiums paid on long-term debt refinancing, loss on refinancing of long-term debt, gains or losses on sales of business units, unrealized gains or losses on derivative financial instruments that do not qualify for hedge accounting, unrealized gains or losses on interest rate swaps, foreign exchange gains

  • r losses on long-term debt, other significant items of an unusual or non-recurring nature, and all such items included in

discontinued operations or in the share of results of our associates and joint ventures. All amounts in this presentation are in Canadian dollars unless otherwise indicated.

slide-3
SLIDE 3

46% 30% 12% 12% Containerboard Tissue Papers Boxboard Europe Specialty Products 33% 32% 20% 15% Containerboard Tissue Papers Boxboard Europe Specialty Products

Segment Sales Breakdown1

COMPANY OVERVIEW

3

  • Founded in 1964 by the Lemaire family;

headquartered in Kingsey Falls, QC

  • Produces, converts and markets packaging & tissue

products composed principally of recycled fibre

  • Balanced play in less cyclical sectors
  • Heavy exposure to two of the strongest paper

segments: Tissue and Containerboard

  • Market leader across many of its primary

product offerings

  • Unique culture – green visionaries, turnarounds,

entrepreneurial philosophy

  • ~ 90 facilities in Canada, US & Europe
  • ~ 11,000 employees worldwide
1 Before inter-segment sales and corporate activities 2 EBITDA excluding specific items

LTM 6/30/16 Net Sales $4,002 million

Segment EBITDA Breakdown1, 2

LTM 6/30/16 EBITDA $456 million

slide-4
SLIDE 4

COMPANY OVERVIEW

Leading Packaging and Tissue Paper Manufacturer

4

Packaging Products

Containerboard

Tissue Papers

Boxboard Europe Specialty Products

Market Position

  • One of the Canadian

leaders

  • # 6 in North America3
  • # 2 in coated recycled

boxboard in Europe

  • Largest paper collector in

Canada

  • # 1 in Canada
  • # 5 in North America

LTM 6/30/16 Financials

  • 33% of Sales1
  • 46% of EBITDA1,2
  • EBITDA Margin2: 18%
  • 20% of Sales1
  • 12% of EBITDA1,2
  • EBITDA Margin2: 7%
  • 15% of Sales1
  • 12% of EBITDA1,2
  • EBITDA Margin2: 11%
  • 32% of Sales1
  • 30% of EBITDA1,2
  • EBITDA Margin2: 12%
1 Before inter-segment sales and corporate activities 2 Excluding specific items 3 Including 100% of Greenpac’s capacity
slide-5
SLIDE 5

5

23% Europe Canada 50% US 27% 23% Europe Canada 37% US 40% 9% Europe Canada 60% US 31% 19% Europe Canada 52% US 29%

Sales from (in %) Sales to (in %) Operating Facilities (in %) PP&E by Geographic Segment (in %)

Note: Figures as of December 31, 2015

COMPANY OVERVIEW

Sales and Operations Across North America and Europe

slide-6
SLIDE 6

285 342 340 426 456 6.0% 8.0% 10.0% 12.0% 14.0% 16.0% 18.0% 200 250 300 350 400 450 500 2012 2013 2014 2015 LTM 6/30/16 3,141 3,370 3,561 3,861 4,002 2,750 3,000 3,250 3,500 3,750 4,000 4,250 2012 2013 2014 2015 LTM 6/30/16

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Strong Financial Momentum

6

Sales EBITDA (excl. specific items)

(M CAN$) (M CAN$)

Positive momentum in results reflect improved productivity and favourable FX & energy costs

  • $3 million EBITDA sensitivity to

every CAN$0.01 change vs US$

slide-7
SLIDE 7

138 133 96 119 154 4% 8% 12% 16% 20% 24% 50 75 100 125 150 175 2012 2013 2014 2015 LTM 6/30/16 37 41 40 58 64 4% 8% 12% 16% 20% 24% 20 40 60 80 100 2012 2013 2014 2015 LTM 6/30/16 43 57 72 63 60 4% 8% 12% 16% 20% 24% 20 40 60 80 100 2012 2013 2014 2015 LTM 6/30/16 90 150 164 231 239 4% 8% 12% 16% 20% 24% 50 100 150 200 250 300 2012 2013 2014 2015 LTM 6/30/16

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Historical Segmented EBITDA

7

Containerboard Boxboard Europe Specialty Products Tissue Papers

(M CAN$) (M CAN$) (M CAN$) (M CAN$)

2012 – LTM6/30/16 CAGR: 17% 2012 – LTM6/30/16 CAGR: 3% 2012 – LTM6/30/16 CAGR: 32% 2012 – LTM6/30/16 CAGR: 10%

1

Green line represents segment EBITDA margin; EBITDA excluding specific items

1 Including $9 million of energy credits
slide-8
SLIDE 8

(0.28) 0.78 0.86 1.58 1.88 (0.50) 0.00 0.50 1.00 1.50 2.00 2012 2013 2014 2015 LTM 6/30/16 155 233 277 337 388 100 200 300 400 500 2012 2013 2014 2015 LTM 6/30/16

1 Excluding specific items 2 Excluding increase in investments

8

Objective: Direct ~$100M of free cash flow annually toward debt reduction

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Cash Flow and Free Cash Flow per Share

Free Cash Flow per Share1,2 Cash Flow From Operating Activities1

  • Cash flows have grown at a 30% CAGR since 2012
  • Improving cash flows driven by Strategic Action Plan

(M CAN$) (CAN$)

slide-9
SLIDE 9

OPERATING PERFORMANCE AND FINANCIAL SITUATION

Debt Maturities

9

  • Over last 24 months, $1 billion+ of

senior notes refinanced

  • Extended maturities to 2021,

2022 and 2023

  • $750 million revolving facility

extended to 2019

  • Average interest rate down 112 bps

to 4.93% in 2015 from 6.05% in 2013

  • Results in annual interest

savings of ~ $23 million

34 125 233 250 710 323 250 500 750 1,000 1 year > 1 year 2019 2021 2022 2023 Debts without recourse Subsidiaries debts Revolver Senior notes

Debt Repayment as at June 30, 2016

slide-10
SLIDE 10

5.8x 5.0x 4.6x 4.7x 4.0x 3.6x 3.6x 3.4x 3.2x 0.0x 1.0x 2.0x 3.0x 4.0x 5.0x 6.0x 2011 2012 2013 2014 2015 Q2-16 2016E 2017E 2018E

10

1 Based on Street’s EBITDA estimates $436 million for 2016 and $432 million for 2017. Assuming stable EBITDA for 2018 ($432 million), FX US$/CAN$ at 1.30 and only $100 1 million of free cash flows dedicated to debt annually.

LEVERAGE TARGET OF 3.0x – 3.5x

Achievable Without Asset Disposals

1 1 1

slide-11
SLIDE 11

60% 70% 80% 90% 100% Q2 2009 Q2 2010 Q2 2011 Q2 2012 Q2 2013 Q2 2014 Q2 2015 Q2 2016

North American Containerboard Producers

36.0 42.0 40.0 44.0 38.0 0.6

2016e

41.2

New capacity

0.5 39.8

2014

0.9

New capacity

40.7

2015e 2018e

42.6

New capacity

0.8

2017e

41.8

New capacity

CONTAINERBOARD PACKAGING GROUP

Environment Still Sound

11

Fundamentals Sound Despite Added Capacity

Industry Operating Rates and Expected Capacity2

(Million s.t.)

% of total capacity

IP 33%

WestRock 19%

GP 10%

PCA 10%

Kapstone 4%

Cascades 4%

Pratt 4% Others 16% Top-5 Producers 76% 2015 Industry Participants

Source: RISI, Deutsche Bank, Company reports and estimates

1 Including 59.7% of Greenpac’s total capacity 2 New capacity, net of capacity shutdowns

2 SP Fiber PCA D3 Yr 2 Pratt Yr 1 Greif Yr 1 IP Valliant Yr 1 Productivity 0.8% Pratt Yr 2 Greif Yr 2 IP Valliant Yr 2 SP Fiber Yr 2

  • Corr. Supplies

Productivity 0.8%

1

(Operating rate)

Kruger Yr 1

  • Corr. Sup. Yr 1

Productivity 0.8% Kruger Yr 2

  • Corr. Sup. Yr 2

Productivity 0.8%

(+2.3%) (+1.2%) (+1.5%) (+1.9%)

Cascades EBITDA increases ~$2.5M with every 1% increase in our utilization rate

slide-12
SLIDE 12
  • Largest recycled linerboard mill in NA:

1,500 st/day of recycled linerboard (26 pounds)

  • State-of-the-art equipment
  • Product differentiation:

Greenpac XP grades represent 82% of total production in Q2/16

CONTAINERBOARD PACKAGING GROUP

Greenpac Mill

12

Note: Greenpac is not consolidated in results, Cascades does not have effective control under IFRS. : daily capacity on XP Grades = 1,425 s.t.

  • Take-or-pay agreement for 81%
  • f the mill’s output
  • 59.7% ownership:
  • Partners include a pension

fund and two independent converters

(s.t./day)

Greenpac Production 764 1,147 1,211 1,300 1,288 1,351 500 1,000 1,500 Q4 2013 Q2 2014 Q4 2014 Q2 2015 Q4 2015 Q2 2016

slide-13
SLIDE 13

9,258 9,720 9,943 10,290 462 223 347 2,500 5,000 7,500 10,000 12,500 2012 New capacity 2014 New capacity 2016e New capacity 2018e 80 100 120 140 160 1996 2000 2004 2008 2012 2016e Indexed U.S. Tissue Demand At-Home 58% At-Home 51% Away-from- Home 42% Away-from- Home 49%

Canada (25%) US (75%)

At-Home 44% Away-from- Home 39% Parent Rolls 17% Branded 56% Private Label 44% Branded 11% Private Label 89%

TISSUE PAPERS GROUP

Strong Position Across the North American Tissue Market

13

1 Source: RISI

CAS Sales by Geography (2015) CAS Sales by End Markets (2015) Tissue Market Demand1 North American Tissue Capacity Additions1

(M s.t.)

(+5.0%) (+2.3%) (+3.5%)

slide-14
SLIDE 14

Market Market Good Better Best Market

14

Source: RISI

TISSUE PAPERS GROUP

Market vs Cascades

Away-from-Home Retail Retail

slide-15
SLIDE 15

15

2015 NORTH AMERICAN TISSUE MANUFACTURERS Capacity ('000 s.t.) Market Share Capacity Retail Capacity AfH 1 Georgia-Pacific 2,849 29% 67% 33% 2 Procter & Gamble 1,494 15% 100% 0% 3 Kimberly-Clark 1,466 15% 67% 33% 4 SCA Tissue NA 772 8% 0% 100% 5 Cascades Tissue 657 7% 62% 38% 6 Clearwater Paper 435 4% 90% 10% 7 KP Tissue 399 4% 77% 23% 8 First Quality Tissue 290 3% 100% 0% 9 Irving Tissue 282 3% 100% 0% 10 Soundview Paper 161 2% 67% 33% Others 936 10% TOTAL 9,742 100%

Source: RISI

TISSUE PAPERS GROUP

Diversified Capacity

slide-16
SLIDE 16

SPECIALTY PRODUCTS GROUP

Stable Source of Revenue and Unique Platform for Innovation

16

  • Largest recycled paper collector in

Canada

  • Major supplier of material for CAS
  • 19 facilities
  • 1.3 million tons processed in 2015
  • Largest producer of honeycomb in

Canada

  • Good growth potential
  • 6 facilities
  • Stable contributor to CAS results
  • Leading producer of papermill packaging
  • 13 facilities
  • JV Share of EBITDA $10-$15M
  • Diversified product offerings and stable revenue stream with leading market positions
  • Recent initiatives have included Cascades Recovery minority (27%) acquisition completed in

December 2015, and restructuring and minority acquisition of Norcan

  • Q2/16 LTM sales (IFRS) of $604M, vs. $814M (Non-IFRS) with JVs at 100%

Recycling and Recovery (~30% of sales1) Consumer Packaging Products (~20% of sales1) Industrial Packaging Products (~50% of sales1)

1 Including 100% of joint ventures
slide-17
SLIDE 17

17

  • ~58% ownership of RdM, a public Italian company; 5 recycled mills & 1 virgin boxboard mill
  • Rationalization of production capacity, consolidation of sales forces, structure simplification and

modernization investments have resulted in improved performance

  • Completed legal transfer of Cascades’ virgin mill in France to RdM in Q2-2016

M

Manufacturing – Recycled grades Manufacturing – Virgin grades

M M MM M M M

#2 Producer of Coated Recycled Boxboard in Europe with Capacity of 885,000 M.T. EBITDA & EBITDA Margin

Energy credits totaling €4M in 2013, €6M in 2014

6% 7% 9% 8% 7% 33 40 48 45 41 10 20 30 40 50 2012 2013 2014 2015 LTM Q2-2016 (M€)

BOXBOARD EUROPE GROUP

Extensive European Platform

slide-18
SLIDE 18

18

OUR FOUR STRATEGIC PRIORITIES

MODERNIZE core operations through focused investments Status: Ongoing OPTIMIZE capital allocation and reduce working capital Status: Ongoing RESTRUCTURE underperforming units Status: Well-advanced INNOVATE to improve and develop processes and products Status: Continuous

1 2 3 4

slide-19
SLIDE 19

19

STRATEGIC PRIORITY: MODERNIZE ± $300M Invested in Modern Equipment

50 100 150 200 2012 2013 2014 2015 2016B (M$) Containerboard Boxboard Europe Specialty Products Tissue Papers Corporate & IT Capital Expenditures

  • Divestitures and free cash

flow have funded Capex

  • 2016 Capex ~ $185M
  • Mainly growth Capex
  • Mostly in the US
  • Impacted by strong US$
  • 2012-2013: investment in

containerboard – now starting to bear fruit

  • 2013-2015: investment in

tissue papers – not yet reflected in results $184M $161M $184M $173M $185M

1

slide-20
SLIDE 20

20

C M C CM M C M C M M M C M C C C CM C CM CM C C

Now the controlling shareholder of a converting plant in Texas Building a brand new converting facility to increase footprint in Western US and increase integration rate (Q1-17) Retail Away-from-Home Manufacturing Converting

M C

TISSUE – INCREASE FOOTPRINT & INTEGRATION

slide-21
SLIDE 21

14.4% 13.5% 12.9% 12.7% 12.3% 11.6% 11.3% 11.4% 10% 12% 14% 16% Q4 2012 Q2 2013 Q4 2013 Q2 2014 Q4 2014 Q2 2015 Q4 2015 Q2 2016

21

STRATEGIC PRIORITY: OPTIMIZE Strategic Initiatives Generating Results

2

% of sales

  • Working Capital reduced by 3.5% = $125M+

Working Capital ONE Cascades, delivering results Capturing savings through:

  • Shared Services
  • Supply Chain
  • Logistics
  • Operational Efficiency
  • Human Resources
slide-22
SLIDE 22

22

From 2011 to Q2 2016:

  • 16 closures
  • 6 asset sales
  • Workforce reduction:

‒ 2,350

  • Sales:

‒ $1,020M

  • EBITDA:

‒ $26M

  • EBITDA Margin:

3%

  • Dopaco division also divested in 2011 to finance Greenpac, Reno and

Papersource investments Data on Asset Sales and Closures1

STRATEGIC PRIORITY: RESTRUCTURE Streamlining the Portfolio

3

1 Excluding Dopaco
slide-23
SLIDE 23

23

STRATEGIC PRIORITY: INNOVATE Objective: 20% of Sales from Innovative Products

4

slide-24
SLIDE 24

24

FOCUSED ON GROWTH AND PRODUCTIVITY

Containerboard Packaging Group Tissue Papers Group Specialty Products Group Boxboard Europe Group GROWTH AREAS

  • Improve processes
  • Grow US converting

footprint

  • Product innovation and

differentiation including ‘lightweighting’

  • Increase US Away-

from-Home segment

  • Expand footprint in

Western & Southern US

  • Grow market presence

in value-added products (Better, Best)

  • Consumer

packaging provides strong growth potential (i.e. food protein packaging)

  • Strengthen presence

in growing markets (i.e. Eastern Europe)

  • Continue to reduce

leverage to provide flexibility

PRODUCTIVITY INITIATIVES

  • Leverage modernized

Canadian asset base

  • Improve utilization rates
  • Continue to improve

performance of Greenpac Mill

  • Lower costs to improve

competitiveness: continue to modernize asset base & optimize logistics (trim & freight)

  • Invest in innovation
  • Continue to secure

strategic sources of recovered material

  • Optimize logistics

and increase integration

  • Strategic investments

to reduce costs and improve quality & margins (such as in energy, automation, capacity creep)

  • IT upgrades

OBJECTIVES

In top 3 in the sector in terms of EBITDA margin EBITDA margin of 13% Grow topline by 10%+

  • ver next 3 years,

improve margins Maintain/grow solid EBITDA contribution

slide-25
SLIDE 25

25

NEAR TERM OUTLOOK

  • Higher volume in Q3
  • FX rate still favourable
  • Energy cost still favourable
  • Containerboard price increases
  • Raw material cost & volume

headwinds in Europe

  • Higher prices for recovered papers

in North America

+ I

2016 – Q3 vs Q2

Boxboard Europe EBITDA Impact Containerboard EBITDA Impact Specialty Products EBITDA Impact Tissue Papers EBITDA Impact Volume Slight increase Slight increase Slight increase Increase Average selling prices Stable Stable Stable Slight increase Raw material costs Slight increase Slight increase Slight increase Slight increase CAN$ vs

  • ther currencies

Stable Stable Stable Stable Energy costs Slight decrease Stable Stable Stable

slide-26
SLIDE 26

POTENTIAL BENEFITS STEMMING FROM OUR INITIATIVES

26

Other sources of growth and incremental value

  • Culture of innovation
  • Good performance from European platform and hidden value of Boralex investment
  • On-going initiatives to improve our business processes

Modernizing our operating platform to increase profitability

  • $185M Capex program in 2016
  • Divestitures and closures of under-performing units
  • Containerboard: sound fundamentals and improved platform
  • Modernized converting platform and improved manufacturing productivity
  • Greenpac to positively contribute to EPS for a second full year in 2016
  • Tissue Papers: strong and growing position in North America
  • Increasing presence in the US with recent expansion initiatives
  • Ramp-up and resulting benefits from recent Capex projects

Potential tailwinds

  • CAD$ weakness
  • More stable economic reality in Canada, the US and Europe
  • China’s economic weakness and favourable impact on recovered paper prices
  • Lower oil and gas costs
  • Benefits of recent price increases (2015-2016)

  

Taking the right steps to position Cascades for the future

slide-27
SLIDE 27

APPENDIX

27

slide-28
SLIDE 28

800 900 1,000 1,100 1,200 1,300 1,400 1,500 1,600

Aug 08 Jan 09 Jun 09 Nov 09 Apr 10 Sep 10 Feb 11 Jul 11 Dec 11 May 12 Oct 12 Mar 13 Aug 13 Jan 14 Jun 14 Nov 14 Apr 15 Sep 15 Feb 16 Jul 16

Tissue Papers - Selected Benchmarks

Virgin parent rolls Recycled parent rolls (US$/s.t.)

250 300 350 400 450 500 550 600 650

Aug 06 Feb 07 Aug 07 Feb 08 Aug 08 Feb 09 Aug 09 Feb 10 Aug 10 Feb 11 Aug 11 Feb 12 Aug 12 Feb 13 Aug 13 Feb 14 Aug 14 Feb 15 Aug 15 Feb 16 Aug 16

Containerboard - Selected Benchmarks

Linerboard 42-lb. unbleached kraft, Eastern U.S. Corrugating medium 26-lb. semichemical, Eastern U.S. (US$/s.t.)

28

BUSINESS DRIVERS – PRICE DYNAMICS

Source: RISI

slide-29
SLIDE 29

29

BUSINESS DRIVERS – SHIPMENTS

  • Shipments were 2% higher in Q2-2016 compared to the previous quarter
  • Manufacturing utilization rates2 hovering around 91% in Q2-2016
  • Containerboard – 93%
  • Boxboard Europe – 92%
  • Tissue Papers – 89%

CAS Total Shipments (‘000 s.t.) CAS Manufacturing Utilization Rate1,2

1 Excludes Specialty Products segment 2 Defined as: Manufacturing internal and external shipments/practical capacity

2,765 2,899 2,924 2,993 2,986

2,600 2,800 3,000 3,200 2012 2013 2014 2015 LTM Q2 2016

92% 93% 93% 92% 92%

90% 92% 94% 96% 2012 2013 2014 2015 2016 YTD

slide-30
SLIDE 30

30

BUSINESS DRIVERS – COGS

Raw materials Chemicals and production supplies Wages and employee benefits expenses Energy Freight Depreciation and amortization Others

LTM Q2-2016

  • Raw materials (including chemicals and supplies) = nearly half of COGS

37% 11% 20% 8% 8% 6% 10%

slide-31
SLIDE 31

700 800 900 1,000 1,100

June 13 Sept 13 Dec 13 Mar 14 June 14 Sept 14 Dec 14 Mar 15 June 15 Sept 15 Dec 15 Mar 16 June 16 Sept 16

(US$/ton)

Virgin Pulp Prices

NBSK NBHK

50 100 150 200

June 13 Sept 13 Dec 13 Mar 14 June 14 Sept 14 Dec 14 Mar 15 June 15 Sept 15 Dec 15 Mar 16 June 16 Sept 16

(US$/ton)

Recycled Fibre Prices

White grades (Basket of products) Brown grades (OCC)

OBM Average Quarterly List Prices Q2-2015 Q1-2016 Q2-2016 Q2/Q2 Q2/Q1 White grades - Basket of products 170 151 154

  • 9%

+2% Brown grades - OCC No. 11 (Northeast) 80 85 90 +13% +6% Virgin Pulp Prices NBSK (Canadian sources delivered to Eastern US) 980 943 980 +0% +4% NBHK (Canada/US sources delivered to Eastern US) 873 873 847

  • 3%
  • 3%

RAW MATERIALS – FIBRE COSTS

31

Current (Sept.) 100 166 995 835 Current (Sept.)

1

Source: RISI

1 Basket of white recycled paper, including grades such as SOP, Hard White Envelope and Coated Book Stock
slide-32
SLIDE 32

1 2 3 4 5 6

32

RAW MATERIALS – SOURCING STRATEGY

Strategy

  • Constant review of our inventory strategy
  • Ensure control over fibre supply with potential

to increase tons under control

  • Develop substitute grades
  • Continue to increase integration rate within CAS
  • Potential to increase virgin content in certain

circumstances

  • Continue to close the loop with customers &

retailers

World Top Recovered Paper Suppliers

Cascades’ NA Recycled Fibre Supply

20151

Most of the fibre supply comes from internal sources, contracts and regular streams

1 Including volume processed for Greenpac

Recovery & Internal 25% Spot 25% Contractual Agreements 23% Regular & Steady Volume (Noncontractual) 27%

Source: RISI

(M Tonnes)

slide-33
SLIDE 33

33

FINANCIAL INFORMATION ON GREENPAC

1 Selected financial data is derived from the internal consolidated financials statements of Greenpac Holding LLC. 2 Selected financial data at the end of the period. 3 Net debt includes term and ECA loans, revolving credit facility, bridge loan and promissory notes from members, net of cash position. Long-

term debt was refinanced on May 6th, 2016.

(in millions of US dollars)

2014 2015 LTM Q2-2016 Sales 210-230 235-250 240-255 Adjusted EBITDA excluding specific items 38-45 65-72 63-70 Adjusted EBITDA excluding specific items - margin 16%-20% 26%-30% 25%-28% Net debt 2,3 270 185 180 Net debt/Adjusted EBITDA excl. specific items ratio 7.1x-6.0x 2.8x-2.6x 2.8x-2.6x Greenpac - Selected financial data 1

Greenpac - Project cost to net debt reconciliation

(in millions of US dollars)

Project cost Equity contribution Tax credit refund Operating cash flow since startup, net of Capex & working cap. Net debt as of June 30, 2016 479 (191) (60) (48) = 180

slide-34
SLIDE 34

34

Greenpac Illustrative EBITDA (US$M) Impact on Cascades’ EPS (CAN$) Illustrative Value per Share 1 (CAN$) 60 $0.08 $1.70 80 $0.17 $2.80 100 $0.27 $3.90 EBITDA Sensitivity ±10 ±$0.55

  • Assuming a conservative multiple, Greenpac adds significant value to the

Cascades story

1 For illustrative purposes only. Using conservative Total Enterprise Value to EBITDA multiple of 7x. Reflecting expected receipt of tax credit.

Does not reflect the views of the Corporation on valuation. Assuming a foreign exchange rate of $1.25 Canadian dollar per US dollar.

GREENPAC IMPACT ON EPS

slide-35
SLIDE 35

CAS LTM EBITDA

(M$ CAN, unless otherwise noted)

(Net of corp. activities) Multiple Value Value/Share Multiple Value Value/Share

  • Containerboard Group

239 5.8x 1,386 7.8x 1,864

  • Boxboard Europe

60 4.5x 270 4.5x 270

  • Specialty Products Group

64 5.7x 365 5.7x 365

  • Tissue Papers Group

154 6.1x 939 8.4x 1,294

  • Corporate Activities

(61) 5.7x (348) 7.3x (445) 456 Total Enterprise Value (and implied multiple) 5.7x 2,613 7.3x 3,348 Add: JV contribution ($10M EBITDA @ 6.0x) 60 60 Subtract: Net Debt @ June 30, 2016 (1,664) (1,664) Implied Equity Value - before adjustments 1,009 $10.69 1,744 $18.47 Add: Boralex stake (market value @ September 21, 2016) 250 $2.65 250 $2.65 Add: Greenpac investment (market value @ 8.0x) 258 $2.74 258 $2.74 Subtract: Minority interest (Reno only, market value @ 4.5x) (77) ($0.81) (77) ($0.81) Implied Equity Value - after adjustments 1,441 $15.27 2,175 $23.05 Share Price @ September 21, 2016 $11.93 $11.93 Implied share price upside potential 28% 93% CAS valuation using current analyst multiples CAS valuation using 2017e average industry multiples

35

ILLUSTRATIVE SUM OF THE PARTS

1 LTM EBITDA as 06/30/2016; EBITDA excluding specific items. 2 Current multiple average of analysts covering Cascades. 3 2017e average industry multiples applied for Containerboard Group and Tissue Papers Group only. Source: Bloomberg.

Comparable companies include: IP, KapStone, Packaging Corp. and WestRock for Containerboard; Clearwater, K-C, KP Tissue and Orchids Paper for Tissue Papers.

1 2 3

slide-36
SLIDE 36

36

Planet Prosperity Partners

  • 12%
  • 3%
  • 12%
  • 6%

+13 %

+6 %

43%

40 %

5.6%

6%

12.7 %

6%

2.6

2.5

97%

85 %

56%

65 %

Result Target Result Target Result Target ENERGY RESIDUAL MATERIAL USAGE WATER SUSTAINABLE PROCUREMENT INNOVATION FINANCIAL PERFORMANCE (ROCE) HEALTH AND SAFETY (OSHA) EMPLOYEE ENGAGEMENT COMMUNITY INVOLVEMENT

SUSTAINABLE DEVELOPMENT –2013-2015 PLAN RESULTS

slide-37
SLIDE 37

37

  • 7%
  • 7%

+5%

  • 10%

+40% +57% +43%

  • 38%

+16%

10,000

hours in 2020

NEW

ENERGY RESIDUAL MATERIAL USAGE WATER SUSTAINABLE PROCUREMENT INNOVATION FINANCIAL PERFORMANCE (ROCE) HEALTH AND SAFETY (OSHA) EMPLOYEE ENGAGEMENT COMMUNITY INVOLVEMENT GREENHOUSE GAS

Planet Prosperity Partners

SUSTAINABLE DEVELOPMENT – 2016-2020 OBJECTIVES

slide-38
SLIDE 38

38

GEOGRAPHICALLY DIVERSIFIED

* Under construction. * Scheduled for the * end of Q1-2017.

slide-39
SLIDE 39

39

For more information:

www.cascades.com/investors Jennifer Aitken, MBA Director, Investor Relations 514-282-2697 or jennifer_aitken@cascades.com